News & Events
64TH ASH Annual Meeting & Exposition: HaemaLogiX Chief Scientific Officer, Dr Rosanne Dunn, to present
10 November 2022
Watch: Everything you need to know about HaemaLogiX right now, CEO interview
12 October 2022
Watch: Chief Manufacturing and Development Officer Tertia Dex explains the KappaMab manufacturing process
15 August 2022
HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate
27 January 2022
Full presentation materials on the novel antigens LMA and KMA at the 63rd annual ASH meeting are now available
15 December 2021
Dr Mary Sartor to present research on LMA and the 10B3 monoclonal antibody developed by HaemaLogiX at ASH 2021
5 November 2021
Platinum leads immuno-oncology company HaemaLogiX’s $10m capital-raising round
12 September 2021
HaemaLogiX Announces the Outcomes of Two Innovation Connections Grant Projects
16 October 2020
Prof Andrew Spencer presents KappaMab Phase 2b interim analysis results at ASH 2019
8 December 2019
